Schulte Roth & Zabel represented Deep Track Capital, while Crandon Law represented TORL BioTherapeutics in the transaction. TORL BioTherapeutics announced its closing of an oversubscribed $158 million Series...
TORL BioTherapeutics’ $158 Million Series B-2 Financing
Avalo Therapeutics’ $185 Million PIPE
Schulte Roth & Zabel represented Commodore Capital in the transaction. In connection with its acquisition of AlmataBio, Avalo Therapeutics, Inc. issued a PIPE consisting of preferred...
Bed Bath & Beyond’s Chapter 11 Filing
Kirkland & Ellis and Cole Schotz are serving as legal counsel to Bed Bath & Beyond. Davis Polk is advising the administrative agent under an asset-based...